Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced professional lab services relationships with two hospital health systems to enhance the quality and value of diagnostic services to patients and their doctors.
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.56 per share, payable on February 3, 2021 to shareholders of record of Quest Diagnostics common stock on January 20, 2021.
Pfizer is poised to apply for emergency use authorization of its COVID-19 vaccine within days after announcing early Wednesday that the final results of its Phase 3 trial conclude the vaccine is 95% effective.
Quest Diagnostics Inc said on Tuesday the nationwide surge in coronavirus cases has led to a slight increase in turnaround time for its COVID-19 testing. Testing orders increased by about 50% compared with the last week of September, Quest said in a weekly testing update https://newsroom.questdiagnostics.com/COVIDTestingUpdates, adding it was also experiencing increasing constraints on supplies, including test kits. Quest said the turnaround time for its COVID-19 molecular diagnostic testing i...
Passive investing in index funds can generate returns that roughly match the overall market. But in our experience...
After teaming up with Catapult Health to drive telehealth in the Covid-19 pandemic, Quest Diagnostics is testing a new breakout.